Eastroc Beverage(SH:605499) 21世纪经济报道·2026-02-05 09:13Core Viewpoint - The Hong Kong IPO market is experiencing significant growth, with a notable increase in the number of new listings and total fundraising amounts, indicating a robust market outlook for 2026 [1][4]. Group 1: IPO Market Performance - As of February 5, 2026, the Hong Kong market has seen 15 new IPOs, a year-on-year increase of 87.50%, with total fundraising reaching 51.307 billion HKD, up 757.71% [1]. - Eastroc Beverage's IPO raised 10.1 billion HKD, marking it as the first IPO in Hong Kong to exceed 10 billion HKD in 2026 [1]. - The consensus in the industry is that both the number of IPOs and the total fundraising in Hong Kong will remain high throughout 2026 [1]. Group 2: IPO Pipeline and Industry Distribution - The "2025 Hong Kong IPO Market and Secondary Market White Paper" indicates that there are over 270 companies in the pipeline for IPOs, with 277 valid applications as of December 31, 2025 [4][5]. - The majority of these companies are concentrated in software services, healthcare, and industrial manufacturing, accounting for over 60% of the total applications [4]. - A significant portion of the applicants, 67.1%, are new entrants to the market, reflecting increased attractiveness of the Hong Kong IPO market [4]. Group 3: Future Projections - Deloitte forecasts approximately 160 new IPOs in 2026, with total fundraising expected to be no less than 300 billion HKD, including 7 IPOs each raising at least 10 billion HKD [4]. - PwC anticipates around 150 new listings with total fundraising between 320 billion and 350 billion HKD, while EY predicts 180 new listings with similar fundraising expectations [5]. Group 4: A+H Companies and Market Dynamics - In 2025, 19 new A+H companies were listed in Hong Kong, with total fundraising reaching 126.946 billion HKD, significantly higher than the previous year's figures [7]. - There are currently 93 A-share companies that have submitted applications to list in Hong Kong, including 9 with market capitalizations exceeding 100 billion RMB [7][8]. - The trend of A+H listings is driven by companies seeking international financing channels, allowing them to mitigate market volatility risks and attract long-term international capital [9]. Group 5: Regulatory Reforms and Market Attractiveness - Recent reforms by the Hong Kong Stock Exchange, including the introduction of the 18A and 18C chapters, have significantly enhanced the attractiveness of the Hong Kong market for biotech and tech companies [11][12]. - The 18A chapter has seen a rise in biotech listings, with 16 companies listed in 2025, raising a total of 13.059 billion HKD [12]. - The 18C chapter has also gained traction, with a total fundraising of 5.915 billion HKD in 2025, indicating a growing interest from tech companies [13].